Martina Brueckmann Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

2/2012	Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
1/2009	Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis?
8/2008	Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
8/2008	Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction.
10/2007	Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martina Brueckmann Research Topics

Disease

54	Heart Failure 08/2022 - 07/2005
36	Atrial Fibrillation 01/2021 - 04/2011
33	Stroke (Strokes) 01/2022 - 01/2012
32	Hemorrhage 01/2021 - 02/2012
18	Sepsis (Septicemia) 09/2014 - 03/2003
16	Embolism (Embolus) 01/2019 - 02/2012
11	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2019
10	Myocardial Infarction 12/2020 - 01/2003
9	Venous Thromboembolism 01/2021 - 01/2016
9	Inflammation (Inflammations) 10/2019 - 01/2003
7	Embolic Stroke 01/2022 - 12/2015
7	Aortic Valve Stenosis (Aortic Stenosis) 09/2008 - 10/2003
5	Thrombosis (Thrombus) 01/2020 - 10/2016
5	Acute Coronary Syndrome 01/2019 - 01/2005
5	Coronary Artery Disease (Coronary Atherosclerosis) 02/2012 - 10/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 11/2017
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 01/2014
3	Hypotension (Low Blood Pressure) 01/2022 - 01/2021
3	Disease Progression 01/2021 - 03/2003
3	Heart Valve Diseases (Valvular Heart Disease) 08/2016 - 07/2004
3	Edema (Dropsy) 01/2015 - 09/2008
3	Dyspnea (Shortness of Breath) 01/2015 - 09/2008
3	Heart Diseases (Heart Disease) 01/2012 - 01/2006
2	Prediabetic State (Prediabetes) 08/2022 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Body Weight (Weight, Body) 01/2021 - 12/2020
2	Chronic Renal Insufficiency 01/2021 - 01/2019
2	Left Ventricular Dysfunction 10/2019 - 08/2008
2	Fibrosis (Cirrhosis) 10/2019 - 04/2011
2	Neoplasms (Cancer) 05/2017 - 12/2014
2	Thromboembolism 03/2016 - 03/2015
2	Septic Shock (Toxic Shock Syndrome) 09/2014 - 03/2003
2	Unstable Angina 02/2012 - 01/2007
2	Infections 01/2009 - 05/2004
2	Ventricular Tachycardia 10/2007 - 01/2004
2	Supraventricular Tachycardia 01/2007 - 01/2004
2	Tachycardia (Tachyarrhythmias) 06/2004 - 01/2004
1	Transient Ischemic Attack 01/2022
1	Gout 01/2022
1	Gouty Arthritis 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 10/2021
1	Albuminuria 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021

Drug/Important Bio-Agent (IBA)

48	Dabigatran FDA Link 01/2022 - 01/2012
41	empagliflozinIBA 08/2022 - 11/2017
27	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2012
21	AnticoagulantsIBA 01/2021 - 01/2012
15	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2004
12	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2004
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2017
12	SodiumIBA 01/2022 - 11/2017
10	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2017
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 12/2015
8	Sodium-Glucose Transport ProteinsIBA 02/2022 - 10/2020
8	Thrombin FDA Link 01/2022 - 12/2015
8	SymportersIBA 01/2021 - 11/2017
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2005
7	Natriuretic PeptidesIBA 01/2021 - 07/2005
7	Protein CIBA 09/2012 - 01/2003
7	Matrix Metalloproteinases (MMPs)IBA 01/2009 - 01/2003
6	Vitamin K FDA Link 01/2021 - 01/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
5	drotrecogin alfa activated (Xigris)FDA Link 12/2008 - 03/2003
4	Clopidogrel (Plavix)FDA Link 01/2019 - 06/2008
4	RivaroxabanIBA 01/2019 - 01/2012
4	Interleukin-6 (Interleukin 6)IBA 09/2014 - 01/2006
4	CytokinesIBA 09/2012 - 01/2004
4	Atrial Natriuretic Factor (ANF)IBA 08/2008 - 01/2004
3	DiureticsIBA 01/2022 - 10/2019
3	Troponin T (Troponin T1)IBA 01/2022 - 01/2021
3	Troponin IIBA 06/2015 - 01/2005
3	apixabanIBA 12/2014 - 01/2012
3	EnzymesIBA 08/2012 - 03/2005
3	AdrenomedullinIBA 01/2010 - 01/2008
3	CalciumIBA 08/2007 - 07/2004
3	Tissue Inhibitor of Metalloproteinase-1IBA 01/2007 - 01/2005
2	CreatinineIBA 01/2022 - 06/2015
2	Neprilysin (Neutral Endopeptidase)IBA 11/2021 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 04/2018
2	TroponinIBA 01/2021 - 11/2017
2	dapagliflozinIBA 01/2020 - 10/2019
2	TicagrelorIBA 01/2019 - 01/2019
2	AntibodiesIBA 01/2018 - 07/2004
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 01/2009 - 11/2005
2	Indicators and Reagents (Reagents)IBA 09/2008 - 08/2008
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2005 - 01/2003
1	Uric Acid (Urate)IBA 01/2022
1	Insulin (Novolin)FDA Link 12/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	CreatineIBA 01/2021
1	AlbuminsIBA 01/2021
1	Fondaparinux (Arixtra)FDA Link 01/2021

Therapy/Procedure

31	Therapeutics 08/2022 - 03/2003
6	Critical Care (Surgical Intensive Care) 01/2021 - 03/2003
4	Percutaneous Coronary Intervention 01/2019 - 01/2007
3	Secondary Prevention 11/2020 - 07/2018
3	Catheter Ablation 11/2013 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2018 - 04/2006